Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer's disease.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
19
09
2019
accepted:
21
11
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
2
4
2020
Statut:
epublish
Résumé
Melanopsin-expressing retinal ganglion cells (mRGCs), intrinsically photosensitive RGCs, mediate the light-based pupil response and the light entrainment of the body's circadian rhythms through their connection to the pretectal nucleus and hypothalamus, respectively. Increased awareness of circadian rhythm dysfunction in neurological conditions including Alzheimer's disease (AD), has led to a wave of research focusing on the role of mRGCs in these diseases. Postmortem retinal analyses in AD patients demonstrated a significant loss of mRGCs, and in vivo measurements of mRGC function with chromatic pupillometry may be a potential biomarker for early diagnosis and progression of AD. We performed a prospective case-control study in 20 cognitively healthy study participants: 10 individuals with pre-symptomatic AD pathology (pre-AD), identified by the presence of abnormal levels of amyloid β42 and total Tau proteins in the cerebrospinal fluid, and 10 age-matched controls with normal CSF amyloid β42 and Tau levels. To evaluate mRGC function, we used a standardized protocol of chromatic pupillometry on a Ganzfeld system using red (640 nm) and blue (450 nm) light stimuli and measured the pupillary light response (PLR). Non-invasive wrist actigraphy and standardized sleep questionnaires were also completed to evaluate rest-activity circadian rhythm. Our results did not demonstrate a significant difference of the PLR between pre-AD and controls but showed a variability of the PLR in the pre-AD group compared with controls on chromatic pupillometry. Wrist actigraphy showed variable sleep-wake patterns and irregular circadian rhythms in the pre-AD group compared with controls. The variability seen in measurements of mRGC function and sleep-wake cycle in the pre-AD group suggests that mRGC dysfunction occurs in the pre-symptomatic AD stages, preceding cognitive decline. Future longitudinal studies following progression of these participants can help in elucidating the relationship between mRGCs and circadian rhythm dysfunction in AD.
Sections du résumé
BACKGROUND
Melanopsin-expressing retinal ganglion cells (mRGCs), intrinsically photosensitive RGCs, mediate the light-based pupil response and the light entrainment of the body's circadian rhythms through their connection to the pretectal nucleus and hypothalamus, respectively. Increased awareness of circadian rhythm dysfunction in neurological conditions including Alzheimer's disease (AD), has led to a wave of research focusing on the role of mRGCs in these diseases. Postmortem retinal analyses in AD patients demonstrated a significant loss of mRGCs, and in vivo measurements of mRGC function with chromatic pupillometry may be a potential biomarker for early diagnosis and progression of AD.
METHODS
We performed a prospective case-control study in 20 cognitively healthy study participants: 10 individuals with pre-symptomatic AD pathology (pre-AD), identified by the presence of abnormal levels of amyloid β42 and total Tau proteins in the cerebrospinal fluid, and 10 age-matched controls with normal CSF amyloid β42 and Tau levels. To evaluate mRGC function, we used a standardized protocol of chromatic pupillometry on a Ganzfeld system using red (640 nm) and blue (450 nm) light stimuli and measured the pupillary light response (PLR). Non-invasive wrist actigraphy and standardized sleep questionnaires were also completed to evaluate rest-activity circadian rhythm.
RESULTS
Our results did not demonstrate a significant difference of the PLR between pre-AD and controls but showed a variability of the PLR in the pre-AD group compared with controls on chromatic pupillometry. Wrist actigraphy showed variable sleep-wake patterns and irregular circadian rhythms in the pre-AD group compared with controls.
CONCLUSIONS
The variability seen in measurements of mRGC function and sleep-wake cycle in the pre-AD group suggests that mRGC dysfunction occurs in the pre-symptomatic AD stages, preceding cognitive decline. Future longitudinal studies following progression of these participants can help in elucidating the relationship between mRGCs and circadian rhythm dysfunction in AD.
Identifiants
pubmed: 31821378
doi: 10.1371/journal.pone.0226197
pii: PONE-D-19-26357
pmc: PMC6903762
doi:
Substances chimiques
Rod Opsins
0
melanopsin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0226197Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JAMA Neurol. 2013 May;70(5):587-93
pubmed: 23479184
Acta Neuropathol. 2016 Dec;132(6):767-787
pubmed: 27645291
Br J Ophthalmol. 2019 Jul;103(7):971-975
pubmed: 30206156
J Comp Neurol. 2018 Sep 1;526(13):2010-2018
pubmed: 29888785
J Comp Neurol. 2014 Jul 1;522(10):2231-48
pubmed: 24752373
Invest Ophthalmol Vis Sci. 2013 Jul 02;54(7):4471-7
pubmed: 23737476
Ophthalmology. 2019 Apr;126(4):511-512
pubmed: 30910035
Front Neurol. 2019 Apr 12;10:360
pubmed: 31031692
Invest Ophthalmol Vis Sci. 2014 Jun 12;55(7):4496-503
pubmed: 24925879
Acta Neuropathol Commun. 2018 Sep 10;6(1):90
pubmed: 30201049
Mol Med Rep. 2016 Apr;13(4):3397-400
pubmed: 26935586
Invest Ophthalmol Vis Sci. 2011 Aug 22;52(9):6624-35
pubmed: 21743008
Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):351-358
pubmed: 30376508
Front Neurol. 2019 Feb 12;10:76
pubmed: 30809186
Vision Res. 2011 Jan 28;51(2):296-302
pubmed: 20691201
Ann Neurol. 2016 Jan;79(1):90-109
pubmed: 26505992
Aging (Milano). 2001 Dec;13(6):473-8
pubmed: 11845975
Ophthalmology. 2009 Aug;116(8):1564-73
pubmed: 19501408
Front Neurol. 2017 May 04;8:162
pubmed: 28522986
Front Aging Neurosci. 2017 Apr 04;9:79
pubmed: 28420980
Curr Eye Res. 2019 Jun;44(6):638-644
pubmed: 30649972
JCI Insight. 2017 Aug 17;2(16):null
pubmed: 28814675
Alzheimers Dement (Amst). 2017 Jan 25;6:162-170
pubmed: 28275698
Brain. 2004 May;127(Pt 5):1061-74
pubmed: 14998915
Eur J Neurosci. 2008 Apr;27(7):1763-70
pubmed: 18371076
J Comp Neurol. 2019 Jan 1;527(1):297-311
pubmed: 30311650
Trends Neurosci. 2011 Nov;34(11):572-80
pubmed: 21816493
Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4202-9
pubmed: 15505076
Front Neurosci. 2016 Nov 17;10:536
pubmed: 27909396
Front Neurol. 2018 Dec 07;9:1047
pubmed: 30581410
Sleep Med Rev. 2015 Feb;19:29-38
pubmed: 24846773
Einstein (Sao Paulo). 2011 Dec;9(4):461-5
pubmed: 26761246
J Comp Neurol. 2017 Jun 1;525(8):1934-1961
pubmed: 28160289
Exp Eye Res. 2015 Jan;130:17-28
pubmed: 25450063
Aging Clin Exp Res. 2015 Oct;27(5):727-33
pubmed: 25749905
Biol Psychiatry. 1990 Mar 15;27(6):563-72
pubmed: 2322616
Histol Histopathol. 2019 Dec;34(12):1299-1311
pubmed: 31219170
PLoS One. 2015 Aug 07;10(8):e0134750
pubmed: 26252902
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1491-1500
pubmed: 30973577
Nature. 2011 Jul 17;476(7358):92-5
pubmed: 21765429
PLoS One. 2013 Nov 18;8(11):e79378
pubmed: 24260210
Neuroimage. 2011 Jan;54 Suppl 1:S204-17
pubmed: 20550967
Int J Mol Sci. 2019 Jun 28;20(13):null
pubmed: 31261700
J Ophthalmol. 2017;2017:7935406
pubmed: 28894607